SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

A Wells Fargo downgrade to Underweight, citing worrying engagement trends and a potentially weaker original-content slate alongside rising live-sports costs, has driven the discussion and selling pressure. Traders are divided between viewing the call as a dubious, opportunistic downgrade and buying the dip, while others worry about intensifying competition and slowing content-driven growth.

The Boeing Co. is an aerospace company, which engages in the manufacture of commercial jetliners and defense, space, and security systems. It operates through the following segments: Commercial Airplanes (BCA), Defense, Space and Security (BDS), and Global Services (BGS). The Commercial Airplanes segment includes the development, production, and market of commercial jet aircraft and provides fleet support services, principally to the commercial airline industry worldwide. The Defense, Space and Security segment refers to the research, development, production and modification of manned and unmanned military aircraft and weapons systems for global strike, including fighter and combat rotorcraft aircraft and missile systems, global mobility, including tanker, rotorcraft and tilt-rotor aircraft, and airborne surveillance and reconnaissance, including command and control, battle management and airborne anti-submarine aircraft. The Global Services segment provides services to commercial and defense customers. The company was founded by William Edward Boeing on July 15, 1916, and is headquartered in Arlington, VA.

Boeing Co.

Boeing Co

Boeing is drawing attention after CEO Kelly Ortberg said stabilizing 737 MAX production is taking longer than expected because of wing-production constraints, while 787 ramp-up and potential China-order expectations also faced uncertainty. Traders largely viewed the comments as a negative operational update and criticized the resulting selloff as an overreaction, with the potential SPEEA strike adding further risk.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

Attention centers on the upcoming Starship Flight 14 launch, with traders debating whether a successful test can extend the stocks momentum; NASAs selection of SpaceX for the StarBurst mission adds to the bullish narrative. Bears counter that the valuation is excessive and upcoming lockup expirations and launch risk could create selling pressure, while others focus on index-rebalance buying and heavy options positioning.

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life-threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in Cleveland, OH.

Abeona Therapeutics Inc

FDA approval of Ultragenyxs FAYUVI gene therapy, formerly Abeonas UX111, is driving attention as traders expect Abeona to receive commercial milestone payments and royalties. The community is largely bullish on the new revenue stream and potential short squeeze, though some traders caution that the rare pediatric indications small market may limit the financial impact.

Boost Run, Inc. is a provider of scalable cloud infrastructure purpose-built for enterprise AI and high-performance computing workloads. The platform delivers GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. The company was founded on September 5, 2025 and is headquartered in Northbrook, IL.

Boost Run Inc. - Ordinary Shares - Class A

Boost Run Inc.

Preliminary inclusion in the Russell 2000 and Russell 3000 is driving attention, with traders anticipating passive-fund buying and increased volume because of the stocks relatively small float. The community is broadly bullish on the index catalyst and recent analyst upgrades, though some remain concerned about insider selling, dilution, and execution risk in the AI infrastructure business.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires post-Buffett leadership transition and Greg Abels stewardship are driving attention, with traders questioning whether the cash-heavy strategy and recent capital allocation can match Buffett-era returns. The community is split between bearish views that prolonged underperformance makes the shares dead money and supporters who see the cash and Treasury holdings as defensive value.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of Fayuvi, the first treatment for Sanfilippo syndrome type A, is driving attention, alongside the associated Priority Review Voucher and potential commercial launch. Traders are broadly bullish on the approval and possible short squeeze, but debate whether the muted share-price reaction reflects limited patient numbers, commercialization and cash-burn concerns, or profit-taking.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

A sharp NEAR rally is drawing attention, with traders citing its AI-agent and chain-abstraction narrative alongside NEAR Intents/Confidential Intents usage and claimed fee-based buybacks. Others argue the move is mainly a liquidity event or short squeeze, pointing to the lack of a clearly confirmed new catalyst.

Securitize Corp. is a financial technology company, which engages in the provision of regulated infrastructure for the issuance, management, trading, and administration of tokenized real-world assets (RWAs). The company was founded on October 17, 2025 and is headquartered in Miami, FL.

Securitize Corp.

An SEC five-year innovation exemption allowing certain platforms to facilitate trading in tokenized U.S. stocks is driving attention, with traders viewing it as a regulatory tailwind for Securitizes digital-asset infrastructure. The community is largely bullish on the tokenization theme and breakout momentum, while some remain concerned about profitability, valuation, and short-term volatility.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

A broad rebound in AI and semiconductor stocks has lifted AMD, with traders also focusing on unverified reports that it may raise prices for select chips as TSMC costs increase. The community is largely bullish on continued AI-driven momentum and a potential short squeeze, while others warn that the move is overextended and vulnerable to a pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Harrow (HROW) Reports Q2 Loss, Misses Revenue Estimates

Harrow (HROW) delivered earnings and revenue surprises of -47.83% and -0.61%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Merck KGaA (MKKGY) Misses Q2 Earnings Estimates

Merck KGaA (MKKGY) delivered earnings and revenue surprises of -44.68% and +3.54%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Aquestive Therapeutics (AQST) Reports Q1 Loss, Beats Revenue Estimates

Aquestive Therapeutics (AQST) delivered earnings and revenue surprises of +50.00% and +33.22%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Heron Therapeutics (HRTX) Reports Q1 Loss, Lags Revenue Estimates

Heron Therapeutics (HRTX) delivered earnings and revenue surprises of -33.33% and -3.91%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know

60 Degrees Pharmaceuticals Inc. (SXTP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

What's Going On With 60 Degrees Pharmaceuticals On Friday?

60 Degrees Pharma shares fall premarket after a huge rally as its babesiosis trial reports a 100% cure rate with tafenoquine treatment.read more...

Promising Small Cap Stocks To Consider - January 22nd

Spring Valley Acquisition, 60 Degrees Pharmaceuticals, and Namib Minerals are the three Small Cap stocks to watch today, according to MarketBeat's stock screener tool. Small-cap stocks are shares of...

Pharmaceutical Stocks To Consider - January 22nd

Abbott Laboratories, Eli Lilly and Company, 60 Degrees Pharmaceuticals, Novo Nordisk A/S, and Pfizer are the five Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool...

60 Degrees Pharmaceuticals Soars After Runway Health Partnership

60 Degrees Pharmaceuticals shares are trading higher after the company announced a partnership with Runway Healthread more...

SXTP Stock Rockets 161% Pre-Market — What Is Driving The Surge?

Equity

60 Degrees has partnered with Runway Health to offer international travelers access to Arakoda via Runway Health’s travel medicine platform.

60 Degrees Pharmaceuticals, Inc. develops medicines for the treatment and prevention of infectious diseases. Its product Arakoda helps in the prevention of malaria. The company was founded by Geoffrey Dow on September 9, 2010 and is headquartered in Washington, DC.

60 Degrees Pharmaceuticals Inc

Extremely Bullish Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Current Price	$0.9926
Prev Close	$0.924
Open	$0.96
Dividend Yield	0.00%
50-Day Moving Average	$1.20
Beta	0.24
Avg. Volume	62,119.40
PE Ratio	-0.16

52-Week High	$8.62
52-Week Low	$0.84
Market Capitalization	$3.25M
EPS (Annual)	-$11.73
Price to Book	-0.38
Revenue Per Employee	$281,819.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

SXTP Fundamentals